ArticleFrontiers in medicine2022

Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma.

Yongkang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.